Trials / Completed
CompletedNCT01802580
Using an Internet Study to Improve Adherence for Psoriasis Patients
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Wake Forest University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To evaluate whether participation in an Internet-based intervention helps improve short-term and long-term psoriasis treatment outcomes, in particular, adherence.
Detailed description
An investigator-blinded, prospective study of subjects with mild to moderate psoriasis will be conducted. Forty subjects ages 18 years and older will be enrolled.The Internet-based survey will be piloted to evaluate its effect on adherence to topical psoriasis medication. Subjects randomized in a 1:1 ratio to the Internet-survey group will log their impression of the state of their psoriasis on a weekly basis. Subjects in both the intervention and control groups will receive standard-of-care topical fluocinonide 0.05% ointment to be applied to affected areas on the skin twice daily. Adherence to fluocinonide will be assessed using Medication Event Monitoring System (MEMS®) caps, electronic monitors affixed to the medication containers. Investigators and subjects will be blinded to the adherence data until the final (Month 12) treatment visit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Internet Survey | |
| DRUG | fluocinonide 0.05% ointment |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2016-03-01
- Completion
- 2016-04-01
- First posted
- 2013-03-01
- Last updated
- 2020-06-04
- Results posted
- 2019-11-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT01802580. Inclusion in this directory is not an endorsement.